Is Regeneron Pharmaceuticals (REGN) halal?
Regeneron Pharmaceuticals is not compliant: its is over the AAOIFI limit. interest-bearing debt is 3.4% of market capitalisation (limit 30%); non-permissible (interest) income is 5% of revenue (limit 5%).
The AAOIFI financial screen
| Test | Result | Limit | Status |
|---|---|---|---|
| Interest-bearing debt ÷ market capitalisation | 3.4% | < 30% | Within limit |
| Non-permissible income ÷ revenue | 5% | < 5% | Close to limit |
About Regeneron Pharmaceuticals
Regeneron Pharmaceuticals, Inc. is a biotechnology company focused on discovering, developing, and commercializing medicines for serious diseases across eye care, immunology, oncology, cardiovascular health, and inflammation. Its current portfolio includes treatments such as Eylea and Eylea HD for retinal and eye disorders, Dupixent for inflammatory and allergic conditions, Praluent for cholesterol management, Libtayo in oncology, and Kevzara for rheumatoid arthritis.…
Open the full analysis in Sanad
Similar companies
- Dallah Healthcare Company
- Saudi Pharmaceutical Industries and Medical Appliances Corporation
- Bristol Myers Squibb
- Pfizer Inc.
- UnitedHealth Group
- CVS Health Corporation
Go deeper on Sanad
Free to look up. These parts are included with a free trial or Sanad Pro.
- 🔒 Fair price and buy pricePRO••••••
- 🔒 Analysis Score (0–100)PRO••••••
- 🔒 Insider trades, last 90 daysPRO••••••
- 🔒 Full financial statements and ratio historyPRO••••••
- 🔒 Alerts when the verdict changesPRO••••••
Frequently asked questions
Is Regeneron Pharmaceuticals (REGN) halal?
Regeneron Pharmaceuticals is not compliant: its is over the AAOIFI limit. interest-bearing debt is 3.4% of market capitalisation (limit 30%); non-permissible (interest) income is 5% of revenue (limit 5%).
What makes a stock halal or haram?
Under AAOIFI Standard 21 a company must first have a permissible core business (no conventional banking or insurance, alcohol, tobacco, gambling or similar). Then interest-bearing debt must be under 30% of its market value and interest income under 5% of its revenue.
How much of Regeneron Pharmaceuticals's dividends should be purified?
About 5% of each dividend, the share of the company's income that is not permissible. Donate that amount rather than keeping it.
How often is this updated?
Prices refresh daily and the ratios update when the company files new financial statements, usually every quarter. This page's data was last updated 2026-09-16.